{"id":172270,"date":"2015-01-06T14:50:58","date_gmt":"2015-01-06T19:50:58","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/more-cancer-trials-treatments-for-holy-cross-patients.php"},"modified":"2015-01-06T14:50:58","modified_gmt":"2015-01-06T19:50:58","slug":"more-cancer-trials-treatments-for-holy-cross-patients","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medical-school\/more-cancer-trials-treatments-for-holy-cross-patients.php","title":{"rendered":"More cancer trials, treatments for Holy Cross patients"},"content":{"rendered":"<p><p>    Cancer patients treated at Holy Cross Hospital in Fort    Lauderdale will have access to more clinical trials and medical    treatments under a new agreement with Massachusetts General    Hospital, the largest teaching hospital of Harvard Medical    School.  <\/p>\n<p>    Dr. Patrick A. Taylor, president and CEO of Holy Cross    Hospital, announced a five-year affiliation with the    Massachusetts teaching hospital that expands a collaboration    that began in 2010.  <\/p>\n<p>    Patients treated at the Michael and Dianne Bienes Comprehensive    Cancer Center at Holy Cross will now have available an    increased number of clinical trials and medical treatments.    Genetic counseling services will be expanded and offered to all    cancer patients. Holy Cross patients also will have access to    specialists at Massachusetts General Hospital Cancer Center and    will receive referrals for second opinions and improved    coordination of care.  <\/p>\n<p>    \"Our relationship with the Massachusetts General Hospital    Cancer Center has been very successful as we collaborate on new    ways to provide leading-edge oncology care to our mutual    patients,\" Taylor said in a written statement. \"This agreement    brings additional access to advanced care for cancer patients    living in South Florida as well as a continuity of care for    their patients as they travel to our community.\"  <\/p>\n<p>    Physicians in both organizations will participate in weekly    multidisciplinary patient case presentations and regular    quality improvement reviews. Patients may choose to have their    medical records shared between specialists at the two    hospitals. Under the agreement, physicians practicing in the    Holy Cross Hospital Michael and Dianne Bienes Comprehensive    Cancer Center will become non-clinical consultant members of    the Massachusetts General Hospital medical staff.  <\/p>\n<p>    \"We are thrilled with the enhanced relationship we have now    with Holy Cross Hospital in Fort Lauderdale,\" said Dr. David P.    Ryan, clinical director of Massachusetts General Hospital    Cancer Center and chief of Hematology Oncology at Mass General.    \"This is our first integrated collaboration outside the New    England area, and we could not have chosen a better partner for    this new way of providing the world's best oncology care to our    mutual patients.\"  <\/p>\n<p>    <a href=\"mailto:dgehrke@sunsentinel.com\">dgehrke@sunsentinel.com<\/a> or    Twitter @donnagehrke  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>More here:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/sunsentinel.feedsportal.com\/c\/34258\/f\/623244\/s\/420d7ffe\/sc\/14\/l\/0L0Ssun0Esentinel0N0Cbusiness0Cconsumer0Cfl0Eholy0Ecross0Epartnership0E20A150A10A60Estory0Bhtml0Dtrack0Frss\/story01.htm\/RK=0\/RS=PcGCMS33ZrVCFFqu56orTWHwSsM-\" title=\"More cancer trials, treatments for Holy Cross patients\">More cancer trials, treatments for Holy Cross patients<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Cancer patients treated at Holy Cross Hospital in Fort Lauderdale will have access to more clinical trials and medical treatments under a new agreement with Massachusetts General Hospital, the largest teaching hospital of Harvard Medical School. Dr.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medical-school\/more-cancer-trials-treatments-for-holy-cross-patients.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[36],"tags":[],"class_list":["post-172270","post","type-post","status-publish","format-standard","hentry","category-medical-school"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/172270"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=172270"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/172270\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=172270"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=172270"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=172270"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}